The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).

In order to represent a more recently circulating SARS-CoV-2 variant, the main study endpoints will now evaluate the VXA-CoV2-3.3 (KP.2 strain) vaccine, and not the VXA-CoV2-3.1 (XBB.1.5 strain) vaccine.

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

North Miami Beach, FL

Doral, FL

Miami, FL

Anniston, AL

Newport News, VA

Cincinnati, OH

Baltimore, MD

Waterbury, MA

Lenexa, KY

Austin, TX

Commons Circle

Sacramento, CA

Vaxart

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Port Orange, FL

DeLand, FL

Tampa, FL

Clearwater, FL

Mount Pleasant, SC

Jupiter, FL

Stockbridge, GA

Palm Beach Research

West Palm Beach, FL

Springer Wellness and Restorative Health

Sunrise, FL

Lauderdale Lakes, FL

Pembroke Pines, FL

Hollywood, FL

Miami Lakes, FL

Hialeah, FL

Medley, FL

Monroe, NC

Palmetto Bay, FL

Cullman, AL

Medical Affiliated Research Center

New Orleans, LA

Virginia Beach, VA

Forest Avenue, Richmond, VA

Woodland International Research Group

Chesterfield, MO

Mentor, OH

Houston, TX

Shadow Creek - Pearland, TX

Southfield, MI

Hartsdale, NY

Chicago, IL

Bridgeport, CT

Mesquite, TX

Plano, TX

Rochester, NY

Endeavor Clinical Trials

Methuen, MA

Omaha, NE

San Angelo, TX

Minneapolis, MN

Colorado Springs, CO

Santa Fe, NM

Albuquerque, NM

Fort Collins

Tucson, AZ

Chandler, AZ

Scottsdale, AZ

San Diego, CA

UCSD AntiViral Research Center

Pomona, CA

Fullerton Office - Family Medicine

Huntington Beach, CA

Anaheim Clinical Trials

Rolling Hills Estates, CA

Dublin, CA

Walnut Creek, CO

Redmond, WA

BioNTech

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

AstraZeneca

Find clinical trials for COVID-19 in Jacksonville, FL

Related conditions:

COVID-19 trials near Jacksonville, FL, USA:

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

Find clinical trials for COVID-19 in .css-epvm6{white-space:nowrap;}Jacksonville, FL

Related conditions:

COVID-19 trials near Jacksonville, FL, USA:

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

Find clinical trials for COVID-19 in Jacksonville, FL